FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis
about
Endocrine fibroblast growth factors 15/19 and 21: from feast to famineThe role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic controlRecent advances in understanding and managing cholestasisRoles of FGFs As Paracrine or Endocrine Signals in Liver Development, Health, and DiseaseFibroblast Growth Factor Signaling in Metabolic RegulationEndocrine FGFs: Evolution, Physiology, Pathophysiology, and PharmacotherapyEnergy metabolism in the liverFXR signaling in the enterohepatic systemBile acids as metabolic regulatorsBridging cell surface receptor with nuclear receptors in control of bile acid homeostasisRegulation of fibroblast growth factor 15/19 and 21 on metabolism: in the fed or fasted stateBile acid nuclear receptor FXR and digestive system diseasesBile acid signaling in metabolic disease and drug therapyMolecular mechanisms of fibroblast growth factor signaling in physiology and pathologyDrosophila melanogaster Acetyl-CoA-carboxylase sustains a fatty acid-dependent remote signal to waterproof the respiratory systemChemical and Hormonal Effects on STAT5b-Dependent Sexual Dimorphism of the Liver TranscriptomeE4orf1: a novel ligand that improves glucose disposal in cell cultureThe Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes.Therapeutic utilities of fibroblast growth factor 19.Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolismFasting serum taurine-conjugated bile acids are elevated in type 2 diabetes and do not change with intensification of insulinFibroblast growth factor 15 deficiency impairs liver regeneration in mice.Non-cell-autonomous activation of IL-6/STAT3 signaling mediates FGF19-driven hepatocarcinogenesis.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice.Identification of novel therapeutic targets in the PI3K/AKT/mTOR pathway in hepatocellular carcinoma using targeted next generation sequencing.Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucoseRoux-en-Y gastric bypass normalizes the blunted postprandial bile acid excursion associated with obesity.Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.Fibroblast growth factor receptor 4 (FGFR4) deficiency improves insulin resistance and glucose metabolism under diet-induced obesity conditions.Bile acid signaling in lipid metabolism: metabolomic and lipidomic analysis of lipid and bile acid markers linked to anti-obesity and anti-diabetes in mice.Tissue-specific actions of the metabolic hormones FGF15/19 and FGF21.Peripheral reduction of FGFR4 with antisense oligonucleotides increases metabolic rate and lowers adiposity in diet-induced obese mice.Gut-brain mechanisms controlling glucose homeostasis.Serum concentrations of fibroblast growth factors 19 and 21 in women with gestational diabetes mellitus: association with insulin resistance, adiponectin, and polycystic ovary syndrome history.Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetesThe combination of ezetimibe and ursodiol promotes fecal sterol excretion and reveals a G5G8-independent pathway for cholesterol elimination.Bile Acid signaling in liver metabolism and diseases.Hu antigen R and tristetraprolin: counter-regulators of rat apical sodium-dependent bile acid transporter by way of effects on messenger RNA stability.A preliminary candidate approach identifies the combination of chemerin, fetuin-A, and fibroblast growth factors 19 and 21 as a potential biomarker panel of successful aging.
P2860
Q24629260-7341BFBB-BF01-40C6-8681-D324A5E9EC13Q24629879-4EFCC2A2-67E3-4C9D-861A-6F89CC14C6C8Q26748537-F65E0879-ACE0-46B9-9BAA-1CC23D180FF5Q26752330-70CA9BE9-D8D1-4640-821C-7466CF47CDC3Q26772751-071D58FD-0626-486C-A157-1718247722C1Q26781556-E7DF648B-C2C2-4883-9292-0BF0855D289EQ26996783-415A92E9-488C-4342-9C48-846EDEE41751Q27014753-2BDB5B17-D9D5-42F1-BA7E-0439EB46EE37Q27022441-68954243-CF9C-454B-8957-6FC759C47848Q27024221-33374593-F310-4573-8908-1D39DAB692A3Q28070054-98205973-D376-4EA3-92AF-F9CD02778CEDQ28085493-DB9E7B6E-4A8D-4F04-8407-361E7949CF65Q28244875-C43D507E-F18B-450B-8FC0-00A04ECF8509Q28291993-781D33DF-827A-4A8C-B7BC-3B9F4AB9987BQ28483041-724A44DE-ABFB-4A84-B8DB-5228948F7A96Q28550623-2BCC71E4-C0C2-4266-8522-C32D4C104160Q28741118-97B37235-0319-4585-A6C5-BFAB626B1ACBQ30234616-89765AB3-3815-4E33-95A7-2A748B8DC35AQ30407643-E3A0D134-EDE7-4060-AB2F-FB4420BAB53BQ30544587-5B9C1531-DF50-4550-9AB4-C973F6D3E602Q33570050-F74B8D27-4562-403B-AF51-E83FC984B864Q33626562-454810E2-9251-4198-90E9-98266CD523FDQ33716459-790BFB22-0A3D-45EA-AD4F-CA37E5EC85C3Q33751398-E09EF6E3-3D87-4C3E-B01D-8C5F67A08797Q33914924-2DFAFDA5-55F5-4DB1-BF55-12FE9BEC427FQ33917547-B9ADD165-81B5-4131-AE06-7BCF7BC3E947Q33920932-E81921DE-9AE1-43CB-9471-9C9856CBF34EQ34146701-A95A2891-4526-47A5-90A3-4D2985F9FE4AQ34366988-46B50F95-59F1-4D8A-BD17-132AB6834EA3Q34430978-1BAF6627-54CE-4C3A-87BC-09746FB15DDBQ34451281-007E1A25-8DE4-4234-8FC2-997321AEAA54Q34778879-DD636510-FEF8-4E84-BF74-38A85D824529Q34901544-6D519A58-272C-4D3D-BD96-EAD89130E0F2Q35029601-3645516E-9D6B-4CCD-BD83-37B27EF41C4BQ35049496-2065D57B-5261-4FE4-AAD4-1CE00B970AB0Q35064262-2ACF6835-A9FC-4DA5-ACF6-0E7CF8174A18Q35217035-FEEC97E5-1B0C-451D-8EE1-6D445BC34334Q35257218-5CFC4883-AD44-42CC-82D3-55BCE48B8E60Q35498525-8AA803FC-DC8B-4A67-91D6-33E7420E7945Q35537498-86403967-ADBD-41EF-8EA7-17BBC4BE0CF7
P2860
FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@ast
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@en
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@nl
type
label
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@ast
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@en
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@nl
prefLabel
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@ast
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@en
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@nl
P2093
P2860
P3181
P356
P1433
P1476
FGF19 as a postprandial, insul ...... protein and glycogen synthesis
@en
P2093
Kelly Suino-Powell
Paul Miller
Sara A Beddow
Serkan Kir
Stephen F Previs
Steven A Kliewer
Varman T Samuel
P2860
P304
P3181
P356
10.1126/SCIENCE.1198363
P407
P577
2011-03-01T00:00:00Z